Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,790,889
-
Total 13F shares
-
30,574,421
-
Share change
-
+677,297
-
Total reported value
-
$389,239,505
-
Put/Call ratio
-
62%
-
Price per share
-
$12.72
-
Number of holders
-
149
-
Value change
-
+$8,058,074
-
Number of buys
-
59
-
Number of sells
-
61
Institutional Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2020
As of 30 Sep 2020,
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,574,421 shares.
The largest 10 holders included
BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, FIRST MANHATTAN CO, Carmignac Gestion, Chescapmanager LLC, BANK OF AMERICA CORP /DE/, STATE STREET CORP, and DISCIPLINED GROWTH INVESTORS INC /MN.
This page lists
149
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.